Ending Drug Ingredient Animal Tests Gains Steam In US Due To Unreliable Human Toxicity Predictions
Executive Summary
Researchers testing OTCs, supplements and cosmetics seek in vitro test alternatives as animal toxicity tests aren’t strong indicators for humans, says consultant John Harbell. At CHPA conference, he says half of drug failures in clinical trials are due to toxicity in humans despite animal tests showing safety.
You may also be interested in...
FDA: Scientific Progress Still Needed To Support Cosmetic Animal Testing Ban
The US FDA is highly engaged in the areas of predictive toxicology and alternative methods to phase out cosmetic animal testing, including evaluation of a 3D-bioprinted human skin model for in vitro permeation testing. However, continued progress is “critically needed” to make feasible the ban on cosmetic animal testing envisioned by US lawmakers, agency leadership suggests.
Cosmetics Sector Needs Positive, Not Punitive, 21st Century Regulation – IBA
Independent Beauty Association president Ken Marenus discusses the trade group’s vision for modern, proportionate cosmetics regulation and forces at work that could undermine progress and endanger small businesses.
Cruelty Free Europe Grieves: ‘Very Little Left Now’ Of Cosmetic Animal-Testing Bans
The European Chemicals Agency's Board of Appeal finds that REACH requires ingredient registrants to perform animal studies, even if their substances are used exclusively in cosmetic products. Historically opposed industry and animal welfare groups both may lose under the board’s decisions.